Fesoterodine Fumarate ER

Strengths & Sizes

Note: product and packaging images are not actual size

NDC#31722-033-30
UPC Code331722033305
ImprintF6/H

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-034-30
UPC Code331722034302
ImprintF7/H

Download Label

Download HDA Sheet

Indications

Fesoterodine fumarate extended-release tablets are indicated for the treatment of: - Overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency. (1.1) - Neurogenic detrusor overactivity (NDO) in pediatric patients 6 years of age and older and weighing greater than 25 kg. (1.2)